The Lysosomal Disease Network is now accepting applications for the next LDN Fellowship, for 2018-2019. Utilizing NIH funding, this research grant provides $50,000 total costs (direct and indirect costs) for the period August 1, 2018 – July 31, 2019. The LDN Fellowship can support currently-ongoing research projects, as well as new research projects. The projects are required to be of a clinical nature, working with people or human tissues; they cannot be non-human medical research.
SUBMISSION DEADLINE: Application deadline is May 1, 2018. Incomplete or late applications are not accepted for review.
Completion of Forms:
Although the current NIH PHS 398 forms must be used (including Face Page, Budget and Budget Justification pages, etc.), the grant will be issued by the University of Minnesota to the applicant’s institution.
The fellowship application does not need to be vetted by the applicant’s institutional administration prior to submission.
The application should cite additional funds, if any, that will be used to support the applicant and the research project prior to, during, and after the Fellowship, in the “Other Support” section of the application (in the Biographical Sketch).
The current PHS 398 forms are available at this website: NIH PHS 398 forms
Application Review Criteria:
Applications will be reviewed for focus on “clinical research” (using human subjects and/or human tissues) of “lysosomal diseases” with priority given to those applicants who are likely to be mentored into a career with a focus on clinical research of lysosomal diseases. The application will also be evaluated with respect to the applicant’s potential to submit a manuscript based on the research proposal to a peer-reviewed journal for publication.
Applications are required to be submitted by e-mail only (please do not send paper copies) by the specified deadline to this e-mail address: firstname.lastname@example.org. Questions can also be sent to that e-mail address.
Thank you for your interest in this Fellowship.
The following LDN Fellows received needed financial support from the LDN in order to provide experiences that developed their skills and expertise in clinical research, benefitting the rare-disease patient community: